Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Neurocognitive Assessment Platform 4 Alzheimer
Authors not listed
IRCCS San Raffaele · 2021
Abstract
The aging population in Europe is leading to an increase in neurodegenerative diseases, such as Alzheimer's disease (AD), which is expected to affect 152 million people worldwide by 2050. In Italy, there are approximately 1.2 million cases of dementia, with 600,000 attributed to AD. Given the limited effectiveness of current pharmacological treatments, there is a growing need for early, non-pharmacological interventions to slow disease progression and improve the quality of life for patients and caregivers.
The Neurocognitive Assessment Platform 4 Alzheimer (NAP4A) study aims to create a digital platform for the early detection of amnestic mild cognitive impairment (MCIa), considered an intermediate stage between normal aging and dementia. The platform uses non-invasive biometric tools, including EEG, blood flow sensors, and eye-tracking devices, to collect neurophysiological and behavioral data.
The study will involve 100 participants aged 55 to 80, divided into two groups: one with individuals diagnosed with MCIa and a control group of healthy participants. Over 12 months, regular assessments will be conducted to identify markers that predict the progression from MCIa to AD. The goal is to develop advanced diagnostic tools that support early and targeted interventions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2021). Neurocognitive Assessment Platform 4 Alzheimer. <em>IRCCS San Raffaele</em>. https://clinicaltrials.gov/study/NCT07272811
Vancouver
Anonymous. Neurocognitive Assessment Platform 4 Alzheimer. IRCCS San Raffaele. 2021.
BibTeX
@misc{anon2021Neuroc,
title = {Neurocognitive Assessment Platform 4 Alzheimer},
author = {Anonymous},
journal = {IRCCS San Raffaele},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Manitoba 2018
Open access · US-GOV
Brain Fitness APP for Aging With a Healthy Brain and Detecting Cognitive Declines
Seoul National University Hospital 2014
Open access · US-GOV
Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease
Journal of Neuroscience 2013
Open access · OA
The Role of -Amyloid in Alzheimer's Disease-Related Neurodegeneration
First Affiliated Hospital of Wenzhou Medical University 2024
Open access · US-GOV
A Longitudinal Study on the Aging of Health and Cognitive Impairment in China
Getúlio Vargas University Hospital 2026
Open access · US-GOV
Use of Wearables for Identifying Factors Associated With Mild Cognitive Impairment and Early-Stage Alzheimer's Disease
Chinese PLA General Hospital 2025
Open access · US-GOV